<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Venlafaxine" /><meta name="IX" content="Venlafaxine" /><title>Venlafaxine: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP2460-venlafaxine-non-proprietary.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP2460-venlafaxine-non-proprietary.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP2460-venlafaxine-non-proprietary.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP2347-antidepressant-drugs.htm">4.3 Antidepressant drugs</a> &gt; <a href="PHP2438-other-antidepressant-drugs.htm">4.3.4 Other antidepressant drugs</a> &gt; <a href="PHP2459-venlafaxine.htm">VENLAFAXINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP2457-tryptophan.htm" title="Previous: TRYPTOPHAN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP2470-cns-stimulants-and-drugs-used-for-attention-deficit-hyperactivity-disorder.htm" title="Next: 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a394020.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Psychotherapeutic Agents 28:16 &gt; Antidepressants 28:16.04 &gt; Selective Serotonin- and Norepinephrine-reuptake Inhibitors 28:16.04.16</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/21820-r.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Venlafaxine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: V &gt; Interactions of Venlafaxine</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="PHP2438-other-antidepressant-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.3.4 Other antidepressant drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.3 Antidepressant drugs</p></div></li><li><a href="PHP2459-venlafaxine.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VENLAFAXINE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.3 Antidepressant drugs &gt; 4.3.4 Other antidepressant drugs</p></div></li><li><a href="PHP2463-venlafaxine-mr-preparations.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine m/r preparations</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.3 Antidepressant drugs &gt; 4.3.4 Other antidepressant drugs &gt; VENLAFAXINE &gt; Modified release</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22venlafaxine%22%22venlafaxine%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c34-mn0001-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0021s0045.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine Hydrochloride</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; V</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/10487-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antidepressants &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09946.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; V &gt; VE</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-V14.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine Hydrochloride</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; V</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E4E3E0R0D101.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Venlafaxine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c380.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Venlafaxine</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; V</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>VENLAFAXINE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int240-venlafaxine.htm">Venlafaxine</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">major depression, generalised anxiety disorder</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">heart disease (monitor blood pressure); diabetes; history of epilepsy; history or family history of mania; susceptibility to angle-closure glaucoma; concomitant use of drugs that increase risk of bleeding, history of bleeding disorders; <strong>interactions:</strong> Appendix 1 (venlafaxine)</p></div> <div class="cG"><div class="cE"><h3 class="cT">Driving</h3> <p class="cT">May affect performance of skilled tasks (e.g. driving)</p></div></div> <div class="cG"><div class="cE"><h3 class="cT">Withdrawal</h3> <p class="cT">Gastro-intestinal disturbances, headache, anxiety, dizziness, paraesthesia, tremor, sleep disturbances, and sweating are most common features of withdrawal if treatment stopped abruptly or if dose reduced markedly; dose should be reduced over several weeks</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">conditions associated with high risk of cardiac arrhythmia, uncontrolled hypertension</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">consider reducing dose by 50% in mild or moderate impairment; use with caution and reduce dose by at least 50% in severe impairment</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">use with caution; use half normal dose (immediate-release tablets may be given once daily) if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">avoid unless potential benefit outweighs risk—toxicity in <em>animal</em> studies; risk of withdrawal effects in neonate</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">present in milk—avoid</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">constipation, nausea, anorexia, weight changes, vomiting; hypertension, palpitation, vasodilatation, changes in serum cholesterol; chills, yawning; dizziness, dry mouth, insomnia, nervousness, drowsiness, asthenia, headache, abnormal dreams, anxiety, confusion, hypertonia, sensory disturbances, tremor; difficulty with micturition, sexual dysfunction, menstrual disturbances; visual disturbances, mydriasis (<em>very rarely</em> angle-closure glaucoma); sweating; <em>less commonly</em> bruxism, diarrhoea, taste disturbance, postural hypotension, arrhythmias, agitation, apathy, incoordination, hallucinations, myoclonus, angioedema, urinary retention, bleeding disorders (including ecchymosis and gastro-intestinal haemorrhage), tinnitus, alopecia, photosensitivity, and rash; <em>rarely</em> mania, hypomania, seizures, extrapyramidal symptoms including akathisia, urinary incontinence; <em>also reported</em> hepatitis, pancreatitis, hypotension, QT-interval prolongation, aggression, neuroleptic malignant syndrome, delirium, vertigo, syndrome of inappropriate anti-diuretic hormone secretion (see <a title="target-block: Antidepressants CSM advice hyponatraemia" href="PHP2347-antidepressant-drugs.htm#PHP2348">Hyponatraemia and Antidepressant Therapy</a>), hyperprolactinaemia, blood dyscrasias, rhabdomyolysis, pruritus, urticaria, Stevens-Johnson syndrome; suicidal behaviour (see <a title="target-block: antidepressants and suicide" href="PHP2347-antidepressant-drugs.htm#PHP2349">Suicidal Behaviour and Antidepressant Therapy</a>)</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Depression, <span class="cP">adult</span> over 18 years, initially 75 mg daily in 2 divided doses increased if necessary at intervals of at least 2 weeks; max. 375 mg daily; <span class="cP">child</span> under 18 years not recommended (see <a title="target-block: CSM advice depression in children" href="PHP2413-selective-serotonin-re-uptake-inhibitors.htm#PHP2414">Depressive Illness in Children and Adolescents</a>)</p><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Faster dose titration may be necessary in some patients</p></div></div></li>  <li><p>Generalised anxiety disorder and social anxiety disorder, see under preparations below</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP2460-venlafaxine-non-proprietary" style="margin: 0 0 0 20px;"><h1 class="title">Venlafaxine <span>(Non-proprietary)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, venlafaxine (as hydrochloride) 37.5 mg, net price 56-tab pack = £2.84; 75 mg, 56-tab pack = £3.75. Label: 3, counselling, driving</p></div></div><ul class="jT"><li id="_PHP2462-modified-release_PHP2462-modified-release"><a href="PHP2462-modified-release.htm#PHP2462-modified-release" title="Modified release">Modified release</a><ul style="display: none"><li><a href="PHP2463-venlafaxine-mr-preparations.htm#PHP2463-venlafaxine-mr-preparations" title="Venlafaxine m/r preparations">Venlafaxine m/r preparations</a></li><li><a href="PHP2464-efexor-xl.htm#PHP2464-efexor-xl" title="Efexor® XL">Efexor® XL</a></li></ul></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP2457-tryptophan.htm">Previous: TRYPTOPHAN</a> | <a class="top" href="PHP2460-venlafaxine-non-proprietary.htm#">Top</a> | <a accesskey="]" href="PHP2470-cns-stimulants-and-drugs-used-for-attention-deficit-hyperactivity-disorder.htm">Next: 4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>